Merck & Co., Inc. (NYSE:MRK) is one of the best affordable stocks to buy with good earnings growth. Merck & Co., Inc. (NYSE:MRK) and Terns Pharmaceuticals, Inc. announced on March 25 their entry into a definitive agreement under which Merck, through a subsidiary, will acquire Terns for $53.00 per share in cash for an approximate equity value of $6.7 billion. Management stated that this translates to around $5.7 billion net of acquired cash, representing an approximate premium of 31% to the 60-day and 42% to the 90-day volume-weighted average stock price on March 24, 2026.

Robert M. Davis, chairman and chief executive officer, Merck & Co., Inc. (NYSE:MRK), stated that the acquisition of Terns builds on the company’s growing presence in hematology with TERN-701, which is a potential best-in-class candidate to treat certain patients with chronic myeloid leukemia. He added that the transaction diversifies and bolsters Merck & Co., Inc.’s (NYSE:MRK) position in oncology, as it continues to look for opportunities that can help the company broaden its portfolio into other therapeutic areas.

Merck & Co., Inc. (NYSE:MRK) is a biopharmaceutical company that delivers health solutions to advance the treatment and prevention of diseases in animals and people. Its Pharmaceutical segment offers vaccines and human health pharmaceutical products, typically therapeutic and preventive agents. Its Animal Health segment develops, discovers, manufactures, and markets a range of vaccines and veterinary pharmaceutical products. The company’s medicine KEYTRUDA may treat certain cancers by working with the immune system.

While we acknowledge the potential of MRK as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.

Disclosure: None. Follow Insider Monkey on Google News.